Patents by Inventor LUDOVIC ARANDEL

LUDOVIC ARANDEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220313843
    Abstract: The present invention relates to the field of gene therapy. In particular, the invention relates to a nucleic acid molecule comprising a nucleic acid sequence able to regulate the expression of a transgene of interest, to a vector or a cell comprising said nucleic acid molecule, and uses thereof.
    Type: Application
    Filed: September 11, 2020
    Publication date: October 6, 2022
    Inventors: DENIS FURLING, LUDOVIC ARANDEL, MAGDALENA MATLOKA, ALAIN SUREAU, MICHEL NEY
  • Publication number: 20210024597
    Abstract: The present invention relates to compositions and methods for treating myotonic dystrophy.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 28, 2021
    Inventors: DENIS FURLING, NICOLAS SERGEANT, MARIE-LAURE CAILLET-BOUDIN, LUDOVIC ARANDEL
  • Patent number: 10799556
    Abstract: The present invention relates to compositions and methods for treating myotonic dystrophy.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: October 13, 2020
    Assignees: ASSOCIATION INSTITUT DE MYOLOGIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Denis Furling, Nicolas Sergeant, Marie-Laure Caillet-Boudin, Ludovic Arandel
  • Publication number: 20170035841
    Abstract: The present invention relates to compositions and methods for treating myotonic dystrophy.
    Type: Application
    Filed: April 14, 2015
    Publication date: February 9, 2017
    Inventors: DENIS FURLING, NICOLAS SERGEANT, MARIE-LAURE CAILLET-BOUDIN, LUDOVIC ARANDEL